| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/03/2013 | CN101808648B Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 04/03/2013 | CN101801414B Oral and skin compositions |
| 04/02/2013 | US8410148 Method and composition for potentiating an opiate analgesic |
| 04/02/2013 | US8410136 Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 04/02/2013 | US8410131 Cancer treatment |
| 04/02/2013 | US8410055 Skin wound healing compositions and methods of use thereof |
| 04/02/2013 | US8409613 Gastric retained gabapentin dosage form |
| 04/02/2013 | US8409612 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409575 Antibodies specific for amyloid beta protofibril |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | US8409561 Methods and compositions for treatment of ion imbalances |
| 04/02/2013 | US8409549 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 04/02/2013 | CA2524603C Controlled release composition containing a strontium salt |
| 04/02/2013 | CA2514327C Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 04/02/2013 | CA2513881C Immunomodulatory compositions |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2452529C Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 03/28/2013 | WO2013043925A1 Sodium channel blockers reduce glucagon secretion |
| 03/28/2013 | WO2013043715A1 Combination treatments comprising c-met antagonists and b-raf antagonists |
| 03/28/2013 | WO2013042122A1 Beta-lactam compounds for enhancing t cell -mediated immune responses |
| 03/28/2013 | WO2010130779A3 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases |
| 03/28/2013 | WO2008076278A8 Methods of cancer treatment with igf1r inhibitors |
| 03/28/2013 | US20130079416 Homeopathic medicament comprising phenacetin for the treatment of cancer |
| 03/28/2013 | US20130079412 Branched 3-phenylpropionic acid derivatives and their use |
| 03/28/2013 | US20130079391 Lipase inhibiting composition |
| 03/28/2013 | US20130079379 Gel compositions of oxymetazoline and methods of use |
| 03/28/2013 | US20130079375 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 03/28/2013 | US20130079366 Benzisoxazoles and Azabenzisoxazoles as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/28/2013 | US20130079355 Use of Flibanserin in the Treatment of Obesity |
| 03/28/2013 | US20130079345 Pharmaceutically active disubstituted triazine derivatives |
| 03/28/2013 | US20130079344 Ophthalmologic irrigation solutions and method |
| 03/28/2013 | US20130079335 Benzotriazolodiazepine Compounds Inhibitors Of Bromodomains |
| 03/28/2013 | US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 03/28/2013 | US20130079329 INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/Beta-CATENIN SIGNALING PATHWAY INHIBITORS |
| 03/28/2013 | US20130079328 Compositions and methods for modulating the wnt signaling pathway |
| 03/28/2013 | US20130079326 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 |
| 03/28/2013 | US20130079318 Beta-lactamase inhibitory compounds |
| 03/28/2013 | US20130079297 Kinase protein binding inhibitors |
| 03/28/2013 | US20130079290 S1p antagonists as adjunct ocular hypotensives |
| 03/28/2013 | US20130078305 Pharmaceutical Compositions For The Coordinated Delivery Of NSAIDs |
| 03/28/2013 | US20130078302 Protein C Zymogen and Methods of Use Thereof to Prevent Cancer Metastases |
| 03/28/2013 | US20130078288 Method of Treating Cancer |
| 03/28/2013 | US20130078286 Drug delivery system |
| 03/28/2013 | US20130078285 Implant for tissue repair |
| 03/28/2013 | US20130078284 Pharmaceutical formulations |
| 03/28/2013 | US20130078256 Novel hiv reverse transcriptase inhibitors |
| 03/28/2013 | US20130078240 4-1bb binding molecules |
| 03/28/2013 | US20130078235 Neuregulin based compositions and uses thereof for preventing, treating or delaying the myocardial ischemia-reperfusion injury |
| 03/28/2013 | US20130078229 Methods and compositions for the treatment of cancer |
| 03/28/2013 | US20130078218 Hepatitis c therapies |
| 03/28/2013 | US20130078217 2'-chloroacetylenyl substituted nucleoside derivatives |
| 03/28/2013 | US20130078215 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 03/28/2013 | US20130078213 Thrombopoietin mimetics |
| 03/28/2013 | CA2849505A1 Sodium channel blockers reduce glucagon secretion |
| 03/28/2013 | CA2849366A1 Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism |
| 03/28/2013 | CA2846630A1 Combination treatments comprising c-met antagonists and b-raf antagonists |
| 03/28/2013 | CA2845388A1 Beta-lactam compounds for enhancing t cell-mediated immune responses |
| 03/27/2013 | EP2573120A1 Anti-human trop-2 antibody having anti-tumor activity in vivo |
| 03/27/2013 | EP2573083A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 03/27/2013 | EP2572730A1 Method for prevention or treatment of metabolic syndrome |
| 03/27/2013 | EP2572715A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572714A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572711A1 Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient |
| 03/27/2013 | EP2571524A1 Anti-viral agents and compositions thereof |
| 03/27/2013 | EP2571515A2 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression |
| 03/27/2013 | EP2571502A1 Theobromine for increasing hdl-cholesterol |
| 03/27/2013 | EP2571501A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 03/27/2013 | EP2571360A1 Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders |
| 03/27/2013 | CN1909780B Medium chain peroxycarboxylic acid compositions |
| 03/27/2013 | CN1852721B Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 03/27/2013 | CN1681791B 8-羟基喹啉衍生物 8-hydroxyquinoline derivative |
| 03/27/2013 | CN1671391B Novel methods and compositions for alleviating pain |
| 03/27/2013 | CN103002893A Therapeutic agent or prophylactic agent for neuropathic pain |
| 03/27/2013 | CN103002873A Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis |
| 03/27/2013 | CN102994507A Retinitis pigmentosa related gene identification, and product, method and use thereof |
| 03/27/2013 | CN102993272A Targeted peptide of epidermal growth factor receptor (EGFR) and application thereof |
| 03/27/2013 | CN102989012A Monitoring and modulating hgf/hgfr activity |
| 03/27/2013 | CN102989006A Preparation method of silicon-nanowire-based medicinal carrier |
| 03/27/2013 | CN102988996A Method for preparing stable albumin nanoparticle |
| 03/27/2013 | CN102988989A Refining and extracting method of dextran by membrane separation |
| 03/27/2013 | CN102988988A Pharmaceutical composition for treating pulmonary aspergillosis |
| 03/27/2013 | CN102988987A Pharmaceutical composition for treating hyperproliferative skin disease and preparation of pharmaceutical composition |
| 03/27/2013 | CN102988986A Male trait inducer and induction method for pelodiscus sinensis in embryonic periods |
| 03/27/2013 | CN102988985A Use of miR-146a as blood vessel growth regulation target |
| 03/27/2013 | CN102988362A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 03/27/2013 | CN102988292A Gypenoside lipidosome consisting of sterol and preparation method thereof |
| 03/27/2013 | CN102218140B Tumor resistance effect of medicine combination of salvianolic acid B and coxib medicaments |
| 03/27/2013 | CN102206247B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus |
| 03/27/2013 | CN102106807B Method for preparing solid preparation and solid preparation |
| 03/27/2013 | CN101797241B Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 03/27/2013 | CN101791410B Preparation and application of conjugate of anti-infective medicament and polysaccharide and medicinal composition thereof |
| 03/27/2013 | CN101590239B Pharmaceutical composition containing uretic, statin and folic acid as well as applications thereof |
| 03/27/2013 | CN101137390B Novel angiogensis inhibitor |
| 03/26/2013 | US8404826 Mycobacterial antigens expressed under low oxygen tension |
| 03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 03/26/2013 | US8404793 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 03/26/2013 | US8404744 Methods of treatment and pharmaceutical composition |
| 03/26/2013 | US8404715 Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors |